Wed, 22 May 2019
We highlight two biotech stocks making oral presentations that could move their share price next month. Plus, Emily Flippen discusses an SEC proposal that could change reporting requirements for early stage biotechs. Stocks: RGNX BPMC Check out more of our content here: |